Geneprodx us a clinical laboratory devoted to the molecular diagnostic of thyroid cancer. Geneprodx developed ThyroidPrint®, a test the will prevent 88% of unnecessary surgery practiced on patients with an undetermined diagnostic. ThyroidPrint® is the only genetic test for thyroid cancer that has been validated in two independent clinical trials: USA and Chile.
Geneprodx is a spin-off from the Pontifical Catholic University of Chile and is the first chilean clinical laboratory to be accredited by the College of American Patologists (CAP).
Visit our ThyroidPrint® website. There you may find all the information that patients and physicians need about this test.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 7500683, Santiago,región Metropolitana De Santiago 8320000,chile
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- thyroidprint.com
- Keywords
- Precision Medicine, FNA, Genomic testing, ThyroidPrint®, CAP, Molecular Pathology, Clinical Laboratory.
- HQ
- Santiago, Región Metropolitana de Santiago
Geneprodx Questions
Geneprodx's website is thyroidprint.com
Geneprodx's LinkedIn profile is https://cl.linkedin.com/company/thyroidprintbygeneprodx
Geneprodx has
18 employees.
View email and phone details for 18
employees at Geneprodx.
Geneprodx's industry is
Biotechnology Research
Geneprodx's top competitors are
Protera,
Inti-Tech,
Palpa®,
Kura Biotech,
Biocartis,
Mycobites,
Phagelab,
Etpay,
Adclean,
Cells For Cells.
Geneprodx's categories are Biotechnology Research
Geneprodx's founding year is 2014
